Two weeks of abstinence resulted in significant improvement of liver disease in AUD patients, as measured by significantly lower CK18-M65 levels and decreased hepatic steatosis by controlled attenuation parameter (CAP; Table 2). The gene discussed is KRT18; the disease is Hepatic steatosis.